Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry

Journal of Virology

Volumn 74, Issue 5, 2000, Pages 2481-2487

  Anderson, Dina B ^a   Laquerre, Sylvie ^a,b   Goins, William F ^a   Cohen, Justus B ^a   Glorioso, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ARTICLE; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VESICULAR STOMATITIS VIRUS; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS MUTANT; VIRUS TYPING;

GENE TARGETING; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MEMBRANE GLYCOPROTEINS; MUTATION; PLASMIDS; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0033961898     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.5.2481-2487.2000     Document Type: Article

References (71)

1. Abe, A., S.-T. Chen, A. Miyanohara, and T. Friedmann. 1998. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein. J. Virol. 72:6356-6361.
2. Akkaraju, G. R., J. Huard, E. P. Hoffman, W. F. Goins, R. Pruchnic, S. C. Watkins, J. B. Cohen, and J. C. Glorioso. 1999. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. J. Gene Med. 1:280-289.
3. Banfield, B., Y. Leduc, L. Esford, R. Visalli, C. Brandt, and F. Tufaro. 1995. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection. Virology 208:531-539.
4. Banfield, B. W., and F. Tufaro. 1990. Herpes simplex virus particles are unable to traverse the secretory pathway in the mouse L-cell mutant gro29. J. Virol. 64:5716-5729.
5. Butcher, M., K. Raviprakash, and H. P. Ghosh. 1990. Acid pH-induced fusion of cells by herpes simplex virus glycoproteins gB and gD. J. Biol. Chem. 265:5862-5868.
6. Cai, W., B. Gu, and S. Person. 1988. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:2596-2604.
7. Chambers, R., G. Y. Gillespie, L. Soroceanu, S. Andreansky, S. Chatterjee, J. Chou, B. Roizman, and R. Whitley. 1995. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. USA 92: 1411-1415.
8. Chatterjee, S., and S. Sarkar. 1992. Studies on endoplasmic reticulum-Golgi complex cycling pathway in herpes simplex virus-infected and brefeldin A-treated human fibroblast cells. Virology 191:327-337.
9. Cheung, P., B. W. Banfield, and F. Tufaro. 1991. Brefeldin A arrests the maturation and egress of herpes simplex virus particles during infection. J. Virol. 65:1893-1904.
10. Chou, J., J. Chen, M. Gross, and B. Roizman. 1995. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 92:10516-10520.
11. Desai, P., P. Schaffer, and A. Minson. 1988. Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes-simplex virus type 1: evidence that gH is essential for virion infectivity. J. Gen. Virol. 69:1147-1156.
12. Dolter, K. E., S. R. King, and T. C. Holland. 1993. Incorporation of CD4 into virions by a recombinant herpes simplex virus. J. Virol. 67:189-195.
13. Fan, D. P., and B. M. Sefton. 1978. The entry into host cells of Sindbis virus, vesicular stomatitis virus and Sendai virus. Cell 15:985-992.
14. Florkiewicz, R. Z., and J. K. Rose. 1984. A cell line expressing vesicular stomatitis virus glycoprolein fuses at low pH. Science 225:721-723.
15. Fredericksen, B. L., and M. A. Whitt. 1996. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion. Virology 217:49-57.
16. Fuller, A. O., and W.-C. Lee. 1992. Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J. Virol. 66:5002-5012.
17. Fuller, A. O., and P. G. Spear. 1985. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. J. Virol. 55:475-482.
18. Geller, A., and X. Breakefield. 1988. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241: 1667-1669.
19. Geller, A., K. Keyomarsi, J. Bryan, and A. Pardee. 1990. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. USA 87:8950-8954.
20. Geraghty, R. J., C. Krummenacher, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618-1620.
21. Gilbert, R., and H. P. Ghosh. 1993. Immunoelectron microscopic localization of herpes simplex virus glycoprotein gB in the nuclear envelope of infected cells. Virus Res. 28:217-231.
22. Gilbert, R., K. Ghosh, L. Rasile, and H. P. Ghosh. 1994. Membrane anchoring domain of herpes simplex virus glycoprotein gB is sufficient for nuclear envelope localization. J. Virol. 68:2272-2285.
23. Goins, W. F., K. A. Lee, J. D. Cavalcoli, M. E. O'Malley, S. T. DeKosky, D. J. Fink, and J. C. Glorioso. 1999. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J. Virol. 73:519-532.
24. L flanking repeats. J. Virol. 68:2239-2252.
25. Goldin, A. L., R. M. Sandri-Goldin, M. Levine, and J. C. Glorioso. 1981. Cloning of herpes simplex virus type 1 sequences representing the whole genome. J. Virol. 38:50-58.
26. Gomez-Navarro, J., J. L. Contreras, W. Arafat, X. L. Jiang, D. M. Krisky, T. Oligino, P. Marconi, W. Arafat, B. Hubbard, J. C. Glorioso, D. T. Curiel, and J. M. Thomas. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a Rhesus model. Gene Ther., in press.
27. Gruenheid, S., L. Gatzke, H. Meadows, and F. Tufaro. 1993. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67:93-100.
28. Herold, B., R. Visalli, N. Susmarski, C. Brandt, and P. Spear. 1994. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulfate and glycoprotein B. J. Gen. Virol. 75:1211-1222.
29. Herold, B. C., S. I. Gerber, T. Polonsky, B. J. Belval, P. N. Shaklee, and K. Holme. 1955. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology 206:1108-1116.
30. Highlander, S. L., S. L. Sutherland, P. J. Gage, D. C. Johnson, M. Levine, and J. C. Glorioso. 1987. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J. Virol. 61: 3356-3364.
31. Ho, D. Y., and E. S. Mocarski. 1989. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc. Natl. Acad. Sci. USA 86:7596-7600.
32. Hunter, W. D., R. L. Martuza, F. Feigenbaum, T. Todo, T. Mineta, T. Yazaki, M. Toda, J. T. Newsome, R. C. Platenberg, H. J. Manz, and S. D. Rabkin. 1999. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J. Virol. 73:6319-6326.
33. Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A. C. Minson, and D. C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:2240-2250.
34. Johnson, D. C., and P. G. Spear. 1982. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J. Virol. 43:1102-1112.
35. Krisky, D. M., P. C. Marconi, T. J. Oligino, R. J. D. Rouse, D. J. Fink, J. B. Cohen, S. C. Watkins, and J. C. Glorioso. 1998. Development of herpes simplex virus replication defective multigene vectors for combination gene therapy applications. Gene Ther. 5:1517-1530.
36. Krisky, D. M., D. Wolfe, W. F. Goins, P. C. Marconi, R. Ramakrishnan, M. Mata, R. J. D. Rouse, D. J. Fink, and J. C. Glorioso. 1998. Deletion of multiple immediate early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5:1593-1603.
37. Krummenacher, C., A. V. Nicola, J. C. Whitbeck, H. Lou, W. Hou, J. D. Lambris, R. J. Geraghty, P. G. Spear, G. H. Cohen, and R. J. Eisenberg. 1998. Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J. Virol. 72:7064-7074.
38. Krummenacher, C., A. H. Rux, J. C. Whitbeck, M. Ponce-de-Leon, H. Lou, I. Baribaud, W. Hou, C. Zou, R. J. Geraghty, P. G. Spear, R. J. Eisenberg, and G. H. Cohen. 1999. The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J. Virol. 73:8127-8137.
39. Lachmann, R. H., and S. Efstathiou. 1997. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J. Virol. 71:3197-3207.
40. Laquerre, S., R. Argnani, D. B. Anderson, S. Zucchini, R. Manservigi, and J. C. Glorioso. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72:6119-6130.
41. Li, Y., C. Drone, E. Sat, and H. P. Ghosh. 1993. Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains. J. Virol. 67:4070-4077.
42. Ligas, M. W., and D. C. Johnson. 1988. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62:1486-1494.
43. Manning, W. C., J. E. Murphy, D. J. Jolly, S. J. Mento, and R. O. Ralston. 1998. Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors. J. Virol. Methods 73:31-39.
44. Marconi, P., D. Krisky, T. Oligino, P. L. Poliani, R. Ramakrishnan, W. F. Goins, D. J. Fink, and J. C. Glorioso. 1996. Replication-defective HSV vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. USA 93:11319-11320.
45. Marlin, S. D., S. L. Highlander, T. C. Holland, M. Levine, and J. C. Glorioso. 1986. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. J. Virol. 59:142-153.
46. Marlin, S. D., T. C. Holland, M. Levine, and J. C. Glorioso. 1985. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. J. Virol. 53:128-136.
47. Matlin, K. S., H. Reggio, A. Helenius, and K. Simons. 1982. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:609-631.
48. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21-30.
49. Mineta, T., S. Rabkin, and R. Martuza. 1994. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res. 54:3963-3966.
50. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
51. Odell, D., E. Wanas, J. Yan, and H. P. Ghosh. 1997. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J. Virol. 71:7995-8000.
52. Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93:11400-11406.
53. Rasty, S., P. Poliani, D. Fink, and J. Glorioso. 1997. Deletion of the S component inverted repeat sequence c′ and the nonessential genes Us1 through Us5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. J. Neurovirol. 3:247-264.
54. Riedel, H., C. Kondor-Koch, and H. Garoff. 1984. Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J. 3:1477-1483.
55. Rux, A. H., S. H. Willis, A. V. Nicola, W. Hou, G. Peng, H. Lou, G. H. Cohen, and R. J. Eisenberg. 1998. Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator. J. Virol. 72:7091-7098.
56. Samaniego, L. A., N. Wu, and N. A. DeLuca. 1997. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71: 4614-4625.
57. Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:3307-3320.
58. Schlegel, R., M. C. Willingham, and I. H. Pastan. 1982. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. J. Virol. 43:871-875.
59. Schneider, M., F. L. Graham, and L. Prevec. 1989. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J. Gen. Virol. 70:417-427.
60. Spaete, R., and N. Frenkel. 1982. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning amplifying vector. Cell 30:295-304.
61. Spear, P. G., M. T. Shieh, B. C. Herold, D. WuDunn, and T. I. Koshy. 1992. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv. Exp. Med. Biol. 313:341-353.
62. Spielhofer, P., T. Bächi, T. Fehr, G. Christiansen, R. Cattaneo, K. Kaelin, M. A. Billeter, and H. Y. Naim. 1998. Chimeric measles viruses with a foreign envelope. J. Virol. 72:2150-2159.
63. Tal-Singer, R., C. Peng, M. Ponce de Leon, W. R. Abrams, B. W. Banfield, F. Tufaro, G. H. Cohen, and R. J. Eisenberg. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69:4471-4483.
64. Terry-Allison, T., R. I. Montgomery, J. C. Whitbeck, R. Xu, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. HveA (herpesvirus entry mediator A), a corcceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J. Virol. 72:5802-5810.
65. Trybala, E., T. Berghtrom, B. Svennerholm, S. Jeansson, J. C. Glorioso, and S. Olufsson. 1994. Localization of the functional site in herpes simplex virus type 1 glycoproteins C involved in binding to cell surface heparan sulfate. J. Gen. Virol. 75:743-752.
66. Weir, J. P., E. J. Dacquel, and J. Aronovitz. 1996. Herpesvirus vector-mediated gene delivery to human monocytes. Hum. Gene Ther. 7:1331-1338.
67. Williams, R. K., and S. E. Straus. 1997. Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans. J. Virol, 71:1375-1380.
68. Wilson, S. P., D. C. Yeomans, M. A. Bender, Y. Lu, W. F. Goins, and J. C. Glorioso. 1999. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus, Proc. Natl. Acad. Sci. USA 96:3211-3216.
69. Wu, N., S. C. Watkins, P. A. Schaffer, and N. A. DeLuca. 1996. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, 1CP27, and ICP22. J. Virol. 70:6358-6369.
70. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
71. Yamada, M., T. Oligino, M. Mata, J. R. Goss, J. C. Glorioso, and D. J. Fink. 1999. HSV vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine induced degeneration of neurons in the substantia nigra in vivo. Proc. Natl. Acad. Sci. USA 96:4078-4083.